Michael R. Loebinger

13.4k citations

150 papers · 5.1k indexed · 3 hit papers · h-index 37

Impact in

Small Animals top 0.2%
- Infectious Diseases and Mycology
Microbiology top 2%

Papers in

Pulmonary and Respiratory Medicine 96
- Cystic Fibrosis Research Advances 79
- Neonatal Respiratory Health Research 40
- Tracheal and airway disorders 33
Small Animals 21
- Infectious Diseases and Mycology 21

Co-authors: Sam M. Janes Robert Wilson Steven Cowman Derek Davies Ayad Eddaoudi David M. Hansell James D. Chalmers Charles Haworth
Journals: European Respiratory Journal (15 papers)Thorax (12 papers)ERJ Open Research (7 papers)CHEST Journal (5 papers)American Journal of Respiratory and Critical Care Medicine (5 papers)
Partner nations: United Kingdom Italy United States

In The Last Decade

Michael R. Loebinger

139 papers receiving 5.0k citations

Hit Papers

align trajectories log scale

Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis 2025 · 26 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2025 New England Journal of Medicine
2020 New England Journal of Medicine
2017 Thorax

Peers

Countries citing papers authored by Michael R. Loebinger

Since Specialization

Citations

This map shows the geographic impact of Michael R. Loebinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael R. Loebinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael R. Loebinger more than expected).

Fields of papers citing papers by Michael R. Loebinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael R. Loebinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael R. Loebinger. The network helps show where Michael R. Loebinger may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael R. Loebinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael R. Loebinger Line = papers co-authored together Michael R. Loebinger links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Improving ototoxicity monitoring in patients receiving aminoglycosides using a novel digital approach: a quality improvement project BMJ Open Quality ·Shayma Al-Najjar, Mark Trayfoot, 武彩霞, Алена Владимировна Искрина, Thorsten Kloepfer, Andrew Jones, Antonius Sukmono, Andrea Leporati, Gülgün Elif Akçalı, Ricardo J. José, Su Madge, Enrique Romerales Espinosa, Emily Frost, H. P. Doub, Michael R. Loebinger, Nicholas J. Simmonds, Francis Drobniewski, Anand Shah	2025	2
2	ANNUALIZED EXACERBATION RATE IN PATIENTS WITH NON-CYSTIC FIBROSIS BRONCHIECTASIS BY PRESPECIFIED SUBGROUPS IN THE PH3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED ASPEN TRIAL CHEST Journal ·Mark L. Metersky, Pierre‐Régis Burgel, Charles L. Daley, Anthony De Soyza, Charles Haworth, David Mauger, Michael R. Loebinger, Timothy R. Aksamit, Naoki Hasegawa, Kozo Morimoto, Felix C. Ringshausen, Kevin C. Mange, Ariel Teper, 健彦好光, M. Deleuile, Xiangmin Zhang, James D. Chalmers	2024	2
3	Changes in Blood Immune Cell Transcriptomes Associate With Disease Severity, Infection, and Inflammation in Bronchiectasis Patients: Data From the EMBARC-BRIDGE Study Malisetty Ravi Teja, Lídia Perea, Júlio Marcente Carlos, Jennifer S. Pollock, Chloe Hughes, Caroline S. Clarke, Michal Shteinberg, Stefano Aliberti, Charles Haworth, Sanjay H. Chotirmall, L Gommers, Pieter Goeminne, Michael R. Loebinger, Zhong Yan, Felix C. Ringshausen, Rosa Faner, Oriol Sibila, Amelia Shoemark, James D. Chalmers	2024	0
4	Automated method of bronchus and artery dimension measurement in an adult bronchiectasis population ERJ Open Research ·Somkanya Tungsanga, Yovi Litanianda, Jennifer J. Meerburg, Aslan Avşarbey, Eleni‐Rosalina Andrinopoulou, Pierluigi Ciet, James D. Chalmers, Michael R. Loebinger, Charles Haworth, J.S. Elborn, Harm A.W.M. Tiddens	2024	1
5	Patients at risk of nontuberculous mycobacterial pulmonary disease who need testing evaluated using a modified Delphi process by European experts ERJ Open Research ·Michael R. Loebinger, Stefano Aliberti, Charles Haworth, Mateja Janković Makek, Christoph Lange, Natalie Lorent, Apostolos Papavasileiou, Eva Polverino, Gernot Rohde, Nicolas Véziris, Dirk Wagner, Jakko van Ingen	2024	1
6	Brensocatib in patients with bronchiectasis: subgroup analyses from the WILLOW trial ERJ Open Research ·James D. Chalmers, Michael R. Loebinger, Ariel Teper, Pamela J. McShane, A El-Daker, 廣道伊川, Charles Haworth, 忠川上, Roald van der Laan, Vivian H. Shih, Mark L. Metersky	2024	3
7	The problem of Mycobacterium abscessus complex: multi-drug resistance, bacteriophage susceptibility and potential healthcare transmission Clinical Microbiology and Infection ·Rebekah M. Dedrick, Lawrence Abad, Nathaniel Storey, Nannapat Meemongkolkiat, Bailey E. Smith, Erika Jean-Bart, Madison Cristinziano, V. R. Kozaeva, Patricia R. Kierski, Michael R. Loebinger, Graham F. Hatfull, Giovanni Satta	2023	10
8	OPTIMA: An Open-Label, Noncomparative Pilot Trial of Inhaled Molgramostim in Pulmonary Nontuberculous Mycobacterial Infection Annals of the American Thoracic Society ·Rachel Thomson, Michael R. Loebinger, Andrew Burke, Lucy Morgan, Grant Waterer, Cecilia Ganslandt	2023	10
9	ERS International Congress 2021: highlights from the Respiratory Infections Assembly ERJ Open Research ·Oliver W. Meldrum, Kylie Belchamber, HN Viswanathan, Khalimov Mr, Ying The Tsai, Merete Long, Melissa J. McDonnell, Lídia Perea, Alberto L. García‐Basteiro, Michael R. Loebinger, Raquel Duarte, Holly R. Keir	2022	1
10	Mycobacterium aviumcomplex genomics and transmission in a London hospital European Respiratory Journal ·Andries J. van Tonder, S. Stoiko, 江梅高, Kartik Kumar, Newara Ramadan, Susan Porter Benson, Julian Parkhill, Miriam F. Moffatt, Michael R. Loebinger, William Cookson	2022	11
11	Clinimetric Properties of Outcome Measures in Bronchiectasis Annals of the American Thoracic Society ·Judy Bradley, Kathryn M. Ferguson, Khafiza Furkat qizi Yusupova, Katherine O’Neill, J. H. Black, Adam T. Hill, Michael R. Loebinger, Mary Carroll, James D. Chalmers, Timothy Gatheral, Christopher Johnson, Anthony De Soyza, John R. Hurst, D.G. Downey, J.S. Elborn	2022	2
12	Utilisation of remote capillary blood testing in an outpatient clinic setting to improve shared decision making and patient and clinician experience: a validation and pilot study BMJ Open Quality ·Николай Олегович Ишков, Victoria Glenn, Jackie Donovan, Melody Ni, Ellie Cripps, Michael R. Loebinger, EE Keaveney, J. H. W. Lee, Anand Shah	2021	17
13	Anxiety and depression in bronchiectasis: Response to pulmonary rehabilitation and minimal clinically important difference of the Hospital Anxiety and Depression Scale Chronic Respiratory Disease ·Urnika Mudhifatul Jannah, Suhani Patel, Ruth E Barker, Sarah E. Jones, Jessica A. Walsh, Samantha S.C. Kon, Е.Л. Куроедова, Michael R. Loebinger, Robert Wilson, William D‐C Man, Claire M. Nolan	2020	45
14	Primary Ciliary Dyskinesia Due to Microtubular Defects is Associated with Worse Lung Clearance Index Lung ·Samantha Irving, Matthew A. Dixon, Mahmoud R. Fassad, Emily Frost, Jane Hayward, R.M. Hadjiiska, Sarah Ollosson, Alexandros Onoufriadis, Mitali Patel, Juliet Scully, S.B. Carr, Hannah M. Mitchison, Michael R. Loebinger, Claire Hogg, Amelia Shoemark, Andrew Bush	2018	19
15	Randomized Phase 3 Trial of Amikacin Liposome Inhalation Suspension (ALIS) for Treatment-Refractory Nontuberculous Mycobacterial (NTM) Lung Disease Caused by Mycobacterium Avium Complex (MAC) in Adult Patients American Journal of Respiratory and Critical Care Medicine ·David E. Griffith, Gina Eagle, Rachel Thomson, Timothy R. Aksamit, Noriko Hasegawa, Haider Baker Ameen, Doreen Addrizzo‐Harris, Anne E. O’Donnell, Theodore K. Marras, Patrick A. Flume, Michael R. Loebinger, Lucy Morgan, Paola Castellotti, A. T. Hill, Stephen J. Ruoss, Jae‐Joon Yim, Felix C. Ringshausen, Stephen K. Field, James Nezamis, Kevin Winthrop	2018	1
16	Six-Minute Walk Test (6MWT) Performance in Adult Patients Receiving Amikacin Liposome Inhalation Suspension (ALIS) for Treatment-Refractory Nontuberculous Mycobacterial (NTM) Lung Disease Caused by Mycobacterium Avium Complex (MAC) American Journal of Respiratory and Critical Care Medicine ·Kevin Winthrop, Gina Eagle, Rachel Thomson, Timothy R. Aksamit, Noriko Hasegawa, Haider Baker Ameen, Doreen Addrizzo‐Harris, Anne E. O’Donnell, Theodore K. Marras, Patrick A. Flume, Michael R. Loebinger, Lucy Morgan, Luigi Ruffo Codecasa, A. T. Hill, Stephen J. Ruoss, Jae‐Joon Yim, Felix C. Ringshausen, Stephen K. Field, James Nezamis, David E. Griffith	2018	0
17	Lung Clearance Index (LCI) is Stable in Most Primary Ciliary Dyskinesia (PCD) Patients Managed in a Specialist Centre: a Pilot Study Lung ·Samantha Irving, S.B. Carr, Claire Hogg, Michael R. Loebinger, Amelia Shoemark, Andrew Bush	2017	10
18	Research priorities in bronchiectasis Thorax ·Anthony De Soyza, Jeremy Brown, Michael R. Loebinger	2012	29
19	Mesenchymal Stem Cell Delivery of TRAIL Can Eliminate Metastatic Cancer Cancer Research ·Michael R. Loebinger, Ayad Eddaoudi, Derek Davies, Sam M. Janes	2009	321
20	Squamous cell cancers contain a side population of stem-like cells that are made chemosensitive by ABC transporter blockade British Journal of Cancer ·Michael R. Loebinger, Adam Giangreco, Karen R. Groot, Lisa Prichard, Kirsty Allen, Catherine Simpson, Laura Bazley, Neal Navani, Sapna Tibrewal, Derek Davies, Sam M. Janes	2008	88

About Michael R. Loebinger

Michael R. Loebinger is a scholar working on Pulmonary and Respiratory Medicine, Small Animals, Microbiology, Emergency Medical Services and Speech and Hearing, having authored 150 papers that have together received 5.1k indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (79 papers), Mycobacterium research and diagnosis (41 papers), Neonatal Respiratory Health Research (40 papers), Tracheal and airway disorders (33 papers), Tuberculosis Research and Epidemiology (26 papers), Infectious Diseases and Mycology (21 papers), Pediatric health and respiratory diseases (19 papers) and Dysphagia Assessment and Management (17 papers). The work is most often cited by research in Small Animals (759 citations), Microbiology (55 citations), Pulmonary and Respiratory Medicine (2.3k citations), Infectious Diseases (1.2k citations) and Epidemiology (2.1k citations). Michael R. Loebinger has collaborated with scholars based in United Kingdom, Italy and United States. Frequent co-authors include Sam M. Janes, Robert Wilson, Steven Cowman, Derek Davies, Ayad Eddaoudi, David M. Hansell, James D. Chalmers, Charles Haworth, Athol U. Wells and David E. Griffith. Their work appears in journals such as European Respiratory Journal, Thorax, ERJ Open Research, CHEST Journal and American Journal of Respiratory and Critical Care Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact